Publication | Closed Access

A polymeric nanoparticle formulation of curcumin in combination with sorafenib synergistically inhibits tumor growth and metastasis in an orthotopic model of human hepatocellular carcinoma

NanoparticlesNanomedicineEngineeringHuman Hepatocellular CarcinomaMedicineTherapeutic NanomaterialsPolymer-drug ConjugatePolymeric Nanoparticle FormulationInhibits Tumor GrowthNano-drug DeliveryTumor TargetingPharmacologyRadiation OncologyTumor Microenvironment